Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DIABETES Mellitus Type 2 Not Well Controlled”

14 trials

Showing 14 of 14 results

Testing effectiveness (Phase 2)Study completedNCT00382239
What this trial is testing

Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 153
Not applicableEnrolling By InvitationNCT06683235
What this trial is testing

Effect of Flaxseed as a Treatment for Adults With Type 2 Diabetes Mellitus in Mexico

Who this might be right for
DIABETES Mellitus Type 2 Not Well Controlled
Universidad Autónoma Benito Juárez de Oaxaca 160
Large-scale testing (Phase 3)Study completedNCT01095653
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,179
Large-scale testing (Phase 3)Study completedNCT00396357
What this trial is testing

Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone

Who this might be right for
Diabetes Mellitus, Type 2
Novartis Pharmaceuticals 914
Large-scale testing (Phase 3)Study completedNCT04504396
What this trial is testing

Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd. 620
Large-scale testing (Phase 3)Study completedNCT00370565
What this trial is testing

Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 345
Large-scale testing (Phase 3)Study completedNCT00528372
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,067
Large-scale testing (Phase 3)Study completedNCT00528879
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 915
Large-scale testing (Phase 3)Study completedNCT01095666
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,484
Not applicableWithdrawnNCT01915264
What this trial is testing

GLucobay M - Evaluation Of Safety and Effectiveness in Type 2 Diabetes Not Well Controlled on Monotherapy in Real Life Practice

Who this might be right for
Diabetes Mellitus, Type 2
Bayer
Large-scale testing (Phase 3)Study completedNCT00577824
What this trial is testing

Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)

Who this might be right for
Type 2 Diabetes
AstraZeneca 181
Testing effectiveness (Phase 2)Study completedNCT01169090
What this trial is testing

A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy

Who this might be right for
Type 2 Diabetes
Kowa Research Institute, Inc. 620
Post-approval studies (Phase 4)Study completedNCT01785043
What this trial is testing

Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users

Who this might be right for
DIABETES Mellitus Type 2 Not Well Controlled
Anna Cruceta 13
Testing effectiveness (Phase 2)Study completedNCT03604419
What this trial is testing

Dose-finding of PB-119 Administered Subcutaneously Once Weekly Versus Placebo in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
PegBio Co., Ltd. 214

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation